Amperos

What it does

End-to-end AI denial management — portal navigation, payer calls, corrected claims, appeals, all autonomous $16M Series A led by Bessemer, 3,000+ clinical locations, $700M revenue recovered/year First AI-native end-to-end denial management platform

Considerations

Denial management ROI depends on appeal win rate and speed of response. Evaluate the platform's performance on your most common denial codes before committing.

This overview was researched by AI from public sources including the vendor's website, regulatory filings, and public announcements. It is not a user review. Have direct experience? Submit a review →

Core features

• Denial management and appeals
• Electronic claims submission
• Automated payer phone calls

Practice size fit

Reviews sourced from G2, Capterra, Google, and Dental Town. Avized does not verify review authenticity.